More articles from MTA I: Radiopharmaceutical Therapy Posters

You have access
First in human alpha radioimmunotherapy with 212Pb-TCMC-trastuzumab
Ruby Meredith, Julien Torgue, Michael Azure, Sui Shen, E. Banaga, R. Carlise, Patty Bunch, Daniel Yoder and Ronald Alvarez

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1372;
You have access
Will Pb-212 trastuzumab succeed in α particle therapy?
ZongJian Cao

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1373;
You have access
Exploring radio-theranostics potentials of a set of ^99mTc/¹⁸⁸Re-labeled RGD-based agents in a tumor-bearing mouse model
Byung Chul Lee, Jae Ho Jung, Byung Seok Moon, Hong Jin Lee, Ho-Young Lee and Sang Eun Kim

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1398;
You have access
Labeling anti-epidermal growth factor receptor variant three monoclonal antibody CH12 with 131I to treatment gliomas: In vitro and in vivo
Wang Lili and Li Peiyong

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1371;
You have access
Effectiveness of Rhenium-188 HEDP for management of metastatic bone pain in patients with prostate cancer: A clinical trial
Augusto Llamas, Carmen de los Reyes, Carlos Rodriguez, Rodolfo Varela, Andres Munar and Juan Castillo

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1406;
You have access
Survival and adverse events after radioembolization of liver metastases from colorectal cancer using glass or resin based yttrium-90 microspheres
Andrei Purysko, Sankaran Shrikanthan and Shyam Srinivas

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1385;
You have access
Long term toxicity studies of ¹⁷⁷Lu-tetraxetan-tetulomab in nude mice
Ada Repetto-Llamazares, Camilla Mollatt, Roy Larsen, Anna Giusti, Elena Riccardi and Jostein Dahle

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1370;
You have access
Labeling, purification, formulation and in vivo evaluation of radioiodinated hypericin as a theragnostic agent for a new anticancer strategy
Marlein Miranda Cona, Junjie Li, Yuanbo Feng, Feng Chen, Alfons Verbruggen, Peter de Witte, Raymond Oyen and Yicheng Ni

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1403;
You have access
Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma
Wan Yu Lin and Tsai-Yueh Luo

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1393;
You have access
Intratumoral positron emission cancer therapy (IPECT) using F-18 FDG, Cu-64 Cl and Ga-68 Cl
Franklin Wong, Katherine Naff, Chengwen Liu, Adrienne Ferguson and Patrick Hwu

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1400;

Main menu

User menu

Search

More articles from MTA I: Radiopharmaceutical Therapy Posters

Pages